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Summary  
Centrosomes and their core structures, the centrioles, are the major microtubule organizing centers 
in animal cells. Polo like kinase 4 (PLK4) is a major player in centriole biogenesis: in its absence 
centrioles fail to form, while in excess leads to centriole amplification [1–5]. PLK4 levels are regulated by 
the SCF-Slimb/βTrCP E3-ubiquitin ligase through recognition of a conserved phosphodegron [6–13]. SCF-
Slimb/βTrCP substrate binding is normally regulated by phosphorylation cascades, which integrate 
diverse signals and regulate timing of protein degradation in complex processes, such as circadian clocks 
and morphogenesis [14, 15]. Here, we show that PLK4 is a suicide kinase, autophosphorylating in 
residues that are critical for SCF-Slimb/βTrCP binding. We demonstrate a multisite trans-
autophosphorylation mechanism, likely to ensure that both a threshold of PLK4 activity is attained and a 
sequence of events is observed before PLK4 can autodestruct. First, PLK4 trans-autophosphorylates 
other PLK4 molecules on both Ser293 and Thr297 within the degron, and these residues contribute 
differently for PLK4 degradation, the first being critical and the second maximising the auto destruction 
process. Second, PLK4 trans-autophosphorylates a phospho-cluster outside the degron, which regulates 
Thr297 phosphorylation, PLK4 degradation and centriole number. Finally, we study the physiological 
relevance of this process and show that PLK4-Slimb/βTrCP is a major mechanism controlling centriole 
number, operating in both soma and germline in Drosophila. As βTrCP, PLK4 and centriole number are 
deregulated in cancers of different tissues [14–18] our work provides novel links between centriole 
number control and tumorigenesis. 
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Graphical abstract 
 
 
 
Highlights  
1. PLK4 trans-autophosphorylates both degron residues Ser293 and Thr297 and a phosphocluster 
that surrounds them  
2. Ser293 is critical whereas Thr297 maximises PLK4 degradation, both ensuring centriole number 
control 
3. Thr297 phosphorylation is regulated by phosphocluster phosphorylation 
4. The PLK4 degron controls kinase protein levels and centriole number in different tissues in the fly  
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Results 
The levels of PLK4 in Drosophila and human cells, and of its homologue Zyg1 in C.elegans, are 
regulated by the SCF-Slimb/βTrCP E3 ubiquitin ligase complex [6–13, 19]. PLK4 contains a conserved 
phospho-degron (DpSGXXpT), whose sequence is often found  in Slimb/βTrCP substrates ([6–13]; Figure 
1A). Typically these substrates present one or more phospho-degrons within their sequence, which 
mediate binding to SCF-Slimb/βTrCP upon phosphorylation [14, 15]. Degron identity and regulation of 
phosphorylation are crucial aspects to control protein degradation and ultimately cellular and 
developmental processes [14, 15]. To fully understand how SCF/Slimb-βTrCP substrates are regulated it 
is particularly important to address how phosphorylation of each individual site in the degron is modulated 
and how the activity and localization of the kinase(s) that phosphorylate the degron(s) is controlled.  
We and others found that phosphorylation of two residues (Ser293 and Thr297) within the PLK4 
SCF-Slimb/βTrCP degron is critical for PLK4 degradation and depends on PLK4 activity. First, a PLK4 
variant that displayed both residues mutated to alanine, hence not being targeted for phosphorylation, 
showed much weaker affinity for Slimb/βTrcp, resulting in high protein stability and centriole amplification 
[7, 9–11, 13, 20]. Second, inactive PLK4 kinase was shown to be stable when compared to the WT [6, 10,  
20]. Moreover, PLK4 was shown to autophosphorylate a region that includes the degron [6, 10, 11], but 
the identity of the phosphorylated residues was not determined due to their close packing [6, 10]. 
Therefore it was suggested that autophosphorylation of degron residues and/or residues surrounding the 
degron contribute to PLK4 binding to Slimb/βTrCP and consequent PLK4 degradation [6, 10, 11].  
Although progress was made towards elucidating PLK4-induced auto destruction, we lack 
mechanistic understanding on how that process is regulated, ensuring a window of time for PLK4 activity 
on centriole biogenesis. It is not currently known which specific phosphorylation residues are involved in 
PLK4 degradation, how their phosphorylation is regulated and how this impacts on centriole number 
control. Furthermore it is not known and is highly debated whether this is a direct mechanism (discussed 
in [11, 21, 22]). On one hand, PLK4 may autophosphorylate residues within and/or outside of the degron 
that regulate binding to Slimb/βTrCP [9, 10]. Alternatively, phosphorylation of PLK4 residues that promote 
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its degradation occurs through an indirect process mediated by a yet unknown kinase whose activity is 
dependent on PLK4 (discussed in [11, 21, 22]). Understanding this complex mechanism is critical to 
elucidate how PLK4 levels, hence centriole numbers, are regulated. 
 
PLK4 autophosphorylates both the Ser293 and Thr297 within the degron  
We first validated that Drosophila PLK4 kinase activity is required for its own degradation through 
the Slimb pathway. We used cell lines in which PLK4 WT (Wild Type) and PLK4 KD (Kinase Dead) mutant 
are fused with Protein A (ProtA) and could be expressed from the inducible methallothionein promoter 
(pMT). Endogenous PLK4 (PLK4) was depleted using dsRNA against the 5’ and 3’ UTR (Figure S1 A, B 
and S2 A, B) to prevent phosphorylation of ectopic PLK4 by the endogenous kinase. We investigated the 
levels of PLK4 for a period of 6 hours after inhibition of protein synthesis by cycloheximide treatment. 
While ProtA PLK4 KD levels remained stable throughout the course of the experiment, ProtA PLK4 WT 
was degraded (Figure S1 A, B). As expected, PLK4 KD mutant expressed always much higher protein 
levels than its WT counterpart in the context of the GFP negative control RNAi (Figure S1 C). Slimb 
depletion led to an accumulation of ProtA PLK4 WT as compared to the GFP negative control, but had 
minimal impact on the levels of ProtA PLK4 KD (Figure S1 C), suggesting Slimb-mediated PLK4 
degradation depends on PLK4 catalytic activity. Moreover, unlike the WT counterpart [7, 13], ProtA PLK4 
KD did not interact with Slimb or SkpA, although other known interactors like Asterless [23–25] were still 
present in PLK4 KD immunoprecipitation assays (Figure S1 D). Together, these data show that 
Drosophila PLK4 protein kinase activity is required for PLK4 degradation via the Slimb pathway. 
To test whether PLK4 phosphorylates its own degron, and which specific residues are involved, we 
developed polyclonal phosphospecific antibodies against the PLK4 degron residues, Ser293 and Thr297 
(Figure 1 B and S1 E). While phosphorylation at both residues was detected with GST PLK4 WT, it was 
absent from GST PLK4 WT kinase co-expressed with Lambda Phosphatase (λppase [26]) (Figure 1 B, 
Figure S1 E), validating those as phospho antibodies. Additionally, these antibodies did not recognize 
proteins specifically mutated to alanine in those residues (S293A and T297A) (Figure 1 D and Figure 4 F, 
G). To address whether PLK4 is able to target directly the degron residues we expressed PLK4 WT in the 
presence or absence of λppase, and KD in bacteria, and probed with different antibodies (Figure 1 B and 
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S1 E). PLK4 WT is highly autophosphorylated in bacteria, which is first evidenced by its slower mobility on 
gel when compared to the condition where PLK4 is co-expressed with λppase or when expressing PLK4 
KD mutant (Figure 1 B and S1 E middle panels). Whereas PLK4 WT is phosphorylated at both residues in 
the degron, phosphorylation is lacking in PLK4 KD mutant indicating that PLK4 autophosphorylates the 
degron (Figure 1 B and S1 E lower panels). As kinases can extensively autophosphorylate within bacteria 
due to high concentrations and long incubation periods, we performed an alternative assay. We purified 
His MBP PLK4 that had previously been dephosphorylated in bacteria and followed its gradual 
autophosphorylation in vitro after addition of ATP (Figure 1C). Autophosphorylation of both residues within 
the degron was observed very early upon addition of ATP (Figure 1 C), showing that PLK4 
autophosphorylates both residues within the degron in a direct manner. These results indicate that PLK4 
can autophosphorylate directly both residues within the typical Slimb degron, in the absence of other 
eukaryotic kinases. 
 To investigate whether other kinases can phosphorylate the degron in vivo, PLK4 
autophosphorylation of the degron was further evaluated in Drosophila tissue culture cells expressing 
different GFP PLK4 constructs after PLK4 endogenous depletion (Figure 1 A, D, S2). Both antibodies 
failed to detect the corresponding single alanine (S293A and T297A) mutants, or the ND (Non-
degradable; both residues mutated (S293A/T297A)) mutant (Figure 1 A, D), validating the site-specificity 
of the antibodies. Whereas GFP PLK4 WT was phosphorylated at both Ser293 and Thr297, the KD 
mutant was not phosphorylated in the degron, showing that PLK4 kinase activity is required for 
phosphorylation of both degron residues in vivo (Figure 1 B, D). We also observed that PLK4 ND mutant 
showed a broader band with slower mobility than its WT counterpart (Figure 1 D). This mobility 
disappeared in the context of the KD mutation (PLK4 KDND; Figure 1 D), showing that the slower mobility 
of the ND mutant results from extensive PLK4-dependent phosphorylation of stable PLK4 variants in 
residues other than the degron. This suggests PLK4 is likely to autophosphorylate many residues outside 
of the degron not just in vitro but in vivo as well.    
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Differential requirement of Ser293 and Thr297 phosphorylation for SCF-Slimb-dependent 
degradation of PLK4 
Since PLK4 autophosphorylates both residues within the degron we wondered what is the impact of 
each of those events on PLK4 stability. Many SCF-Slimb substrates have the typical DS/TG(X)2+nS/T 
degron sequence. Both β−catenin degron phosphoserines DSGIHS form specific hydrogen bonds and 
electrostatic interactions with residues in the βTrCP WD-40 domains, suggesting a requirement for both 
residues concerning βTrCP docking [27]. However, this is not always the case and the contribution of 
each phospho-residue for efficiency and timing of substrate degradation can be different, modulating 
protein degradation [14, 15]. To investigate how the individual Ser293 and Thr297 within the conserved 
Slimb degron contribute for PLK4 degradation we analyzed the kinetics of degradation of two single site 
degron mutants, ProtA PLK4 S293A and ProtA PLK4 T297A. While ProtA PLK4 ND levels remained 
stable throughout the course of the experiment, ProtA PLK4 WT was degraded (Figure 2 A, B). 
Importantly, ProtA PLK4 S293A remained stable throughout the course of the experiment (similarly to 
ProtA PLK4 ND), whereas ProtA PLK4 T297A showed slower degradation, indicating different 
requirements for each residue in PLK4 degradation (Figure 2 A, B). These results suggest that while 
autophosphorylation of S293 is critical for PLK4 degradation, autophosphorylation of Thr297 sets the 
speed at which PLK4 is degraded and thus determines the efficiency of this process. 
If the phosphorylation of the residues within the degron imparts differently the kinetics of PLK4 
degradation, we would expect ultimately to find differences in centriole number upon expression of the 
different mutants. To investigate how the relative stability of each mutant impinges on centriole 
biogenesis, we analyzed the formation of supernumerary centrosomes. We expressed different GFP-
tagged PLK4 variants, at very low levels from the leakiness of the pMT promoter, in an RNAi background 
for endogenous PLK4 (Figure 2 C, D and Figure S2 A, B), and used GFP PLK4 ND as a positive control 
[13]. As expected we observed a systematic increase in centriole amplification (> 4 centrioles) with GFP 
PLK4 S293A -expressing cells relative to GFP PLK4 WT (Figure 2 C, D). GFP PLK4 T297A elicited a 
modest, but significant increase in centriole number compared with the WT, showing that maximum 
efficiency in PLK4 degradation is necessary to prevent deregulation of centrosome number (Figure 2 C, 
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D). The regulation of autophosphorylation of both residues is thus important for controlling the levels of 
PLK4 and ultimately centriole number. 
 
PLK4 phosphorylates both Ser293 and Thr297 in trans 
 Our results show that PLK4 is a suicide kinase, i.e. whose activity determines its own degradation 
through autophosphorylation of two residues. This is in contrast to many other processes regulated by 
Slimb/βTrCP, where a third molecule (sometimes also a fourth) is required to phosphorylate the 
Slimb/βTrCP substrate, hence determining the time of degradation [28, 29]. How could PLK4 self-
destruction be regulated so that it is not immediately degraded and PLK4 can have the time to trigger 
centriole biogenesis? One possibility is that phosphorylation of at least one of the residues within the 
degron is regulated by one or more events dependent on PLK4, but independent of other eukaryotic 
proteins, as degron phosphorylation can also occur in vitro (Figure 1 B, C).  
Interaction of PLK4 molecules in trans is important for PLK4 degradation, but it is not known which 
specific residues might be phosphorylated and how this is regulated [6, 8, 11]. We tested whether PLK4 
can phosphorylate one or both degron residues in trans, i.e. one molecule of PLK4 phosphorylating 
another PLK4 molecule, hence providing some temporal and/or spatial control of degradation. We co-
expressed Myc PLK4 WT and GFP PLK4 KD in Drosophila tissue culture cells (Figure 3 A-C). We chose 
those tags to ensure different protein size. In this experiment we expressed much lower levels of the WT 
kinase as compared to the KD to reduce the probability of encounter between two WT molecules and 
preferentially examine the behavior of the KD in the presence of the WT (Figure 3B, right panel, left and 
middle lanes). When GFP PLK4 KD was co-expressed with GFP empty control (not shown) it showed a 
strongly defined band as expected (Figure 3 B, middle lanes). Co-expression of the WT and KD led to a 
shift in the mobility of the latter, likely to be associated with KD phosphorylation by the WT kinase (Figure 
3 B, middle and right lanes). This shift in mobility in PLK4 KD was accompanied by phosphorylation of the 
degron residues (Figure 3 C, lower panels in each blot). This data suggests that PLK4 trans-
phosphorylates both the Ser293 and Thr297 residues within the degron in vivo.   
It is possible that PLK4 phosphorylation in trans involves oligomerization of the kinase [6, 8, 11]. 
PLK4 has a triple polo box architecture [8] that facilitates oligomerization and targeting [8, 11, 30]. It has 
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been suggested that homodimerization through PB1 and PB2 is important to promote PLK4 binding to 
Slimb and degradation [8, 11].The fact that co-expression of the dimerization domain PLK4 PB1-PB2- 
leads to stabilization of PLK4 WT and centriole amplification [8, 11] suggests that PLK4 targets the degron 
in trans within a dimer. Those experiments suggest that C-terminal constructs containing the polo boxes 
and lacking the kinase domain sequester full length PLK4 through dimerization but cannot phosphorylate 
it on the degron. In order to test whether dimerization through PB1 and PB2 is necessary for Ser293 
and/or Thr297 phosphorylation, we co-expressed the dimerization domain of PLK4 (PLK4 PB1-PB2) with 
the full length in the context of RNAi for the endogenous PLK4, and accessed the impact on degron 
phosphorylation. If dimerization of PB1-PB2 is required for phosphorylation either at Ser293 or Thr297, 
then those residues should be less phosphorylated in PLK4 WT when co-expressed with PB1-PB2, as 
compared with GFP alone. While we observed phosphorylation at the two residues in the WT kinase, 
Ser293 phosphorylation was markedly reduced upon co-expression of PLK4 PB1-PB2, suggesting that 
dimerization through the PB1-PB2 domain is necessary for trans-phosphorylation at that specific residue 
(Figure S 3). The same was not true for Thr297, suggesting that dimerization through PB1-PB2 (cryptic 
polo box, CPB) is not required for Thr297 trans-autophosphorylation. We conclude that 
autophosphorylation of both residues within the degron is likely to be differently regulated, with the critical 
S293 residue requiring dimerization through CPB. A window of activity for PLK4 might thus be created by 
the fact that sufficient levels of PLK4 need to accumulate so that one molecule of PLK4 encounters 
another to dimerise and phosphorylate it at S293, the critical destruction residue.  
 
A phosphocluster around the typical Slimb/βTrCP degron regulates degron phosphorylation and 
controls timely degradation of PLK4  
Could additional mechanisms regulate the timing of PLK4 degradation? In other substrates of 
Slimb/βTrCP, phospho-residues outside the typical Slimb degron regulate the interaction with 
Slimb/βTrCP directly by raising the affinity of the substrate to the WD-40 domain in Slimb/βTrCP and/or 
indirectly regulating degron phosphorylation [29, 31–33]. Multisite phosphorylation-triggered degradation 
is a common strategy in signaling and cell cycle transitions, creating a temporal threshold [34]. Drosophila 
Slimb sequence is ~73% similar to that of human βTrCP (data not shown). The crystal structure of βTrCP 
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displays seven WD repeats, which help to form the conical frustum and the substrate binding groove. The 
positive charged amino acids in βTrCP, which play crucial role in binding to the phosphorylated, hence 
negatively charged, destruction motif of the substrate (e.g., β-catenin [27]), are conserved in Drosophila 
Slimb. A careful observation of the residues on the surface of the WD40 repeat region of Drosophila Slimb 
shows that positive charged residues are regularly distributed along the slant surfaces of the conical 
frustum (data not shown). Drosophila PLK4 has several putative phospho-residues around the DSGIIT 
degron (Figure 4 A), several of which might be autophosphorylated as they fit into the broad PLK4 
phosphorylation consensus site (reviewed in [21]). This part of the protein is highly phosphorylated in 
murine PLK4 but the identity of these residues is unknown due to their close packing that hindered their 
identification [6, 10]. Six of those residues in Drosophila are conserved in murine PLK4, where they are 
likely to be autophosphorylated in vitro and known to participate in PLK4 degradation [10] (Figure 4 A). 
Mass spectrometry of in vitro reactivated PLK4 enabled us to identify individual phosphorylation in at least 
5/6 of those residues, plus the Ser293 and Thr297 at the degron (Figure 4 A and S4 A). The 
phosphorylated residues present around the destruction motif of PLK4 might thus play a very important 
role in regulating the kinetics of PLK4 binding to Slimb, through electrostatic interactions.  
To address whether and how multisite phosphorylation impacts in PLK4 degradation and centriole 
number control, we generated a mutant where we converted all of those conserved residues to alanine 
(PLK4 6A; 6 alanine mutant; Figure 4 A). One hypothesis is that phosphorylation of those residues 
regulates direct binding to Slimb. To evaluate whether phosphorylation at the 6 conserved phospho-
residues around Drosophila Slimb degron is important for Slimb binding and PLK4 degradation we 
analyzed PLK4 6A affinity for Slimb and its degradation, using ProtA PLK4 ND as a positive control. 
Binding to Slimb and PLK4 degradation kinetics were both impaired with PLK4 6A in comparison to the 
negative control (ProtA PLK4 WT) (Figure S 4, 4 B). Impairing binding to Slimb and degradation with the 
PLK4 6A mutant should ultimately lead to centriole amplification in vivo. Indeed we observed that 
expression of PLK4 6A leads to centriole amplification to a similar extent to PLK4 Thr297A (Figure 4 D,E). 
As with other degron mutants PLK4 6A is localized at the centrioles (Figure 4 E). These data indicate that 
phosphorylation around the degron in Drosophila PLK4 is required for efficient binding to Slimb and hence 
for centriole number control.  
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 In other Slimb/βTrCP substrates, phosphorylation of similar clusters primes the timed 
phosphorylation of the conserved degron [29, 31–33]. Phosphorylation at those clusters controls when the 
conserved degron is phosphorylated and consequently determines when the substrate is degraded [28]. 
We tested whether there are regulatory phosphorylations that modulate PLK4 levels, which could enforce 
a sequence of events. We found that neither phosphorylation of Ser293 or Thr297 depends on each other 
phosphorylation (Figure 4 F,G). However, while phosphorylation of Ser293 was not affected in a PLK4 6A 
mutant (Figure 4 F), phosphorylation of the Thr297 residue was highly impaired (Figure 4 G), suggesting 
that PLK4 phosphorylation around the degron primes PLK4 autophosphorylation at the Thr297 residue. 
The fact that Ser293 phosphorylation is well detected in the PLK4 6A mutant, together with its proper 
centriole localization and ability to induce centriole formation (Figures 4 D,E and F) strongly suggest that 
those mutations do not substantially alter the structure of the protein, and can be used to infer the 
behavior of non-phosphorylated PLK4 at the area surrounding the degron. Increasing the phospho-
occupancy around the degron thus regulates the phosphorylated state of the Thr297 residue within the 
degron. This result suggests that phospho-occupancy around the degron is important to set PLK4 
degradation speed. 
Finally, we tested whether phosphocluster phosphorylation may also occur in trans. For this 
experiment we used priming of Thr297 phosphorylation as an indirect readout of phosphocluster 
phosphorylation. We expressed simultaneously Myc PLK4 ND with either GFP PLK4 KD 6A or GFP PLK4 
KD and asked whether phosphorylation of PLK4 KD 6A was impaired at Thr297. Myc PLK4 ND was used 
to simplify the experiment as it is not detected by the Ser293 and Thr297 phosphospecific antibodies. If 
phosphorylation of the cluster were to occur in cis then neither GFP PLK4 KD 6A or GFP PLK4 KD should 
be phosphorylated in the cluster when co-expressed with Myc PLK4 ND; as such both should show 
reduced levels of phosphorylation at the Thr297 residue. However, if phosphorylation of the 
phosphocluster were to occur in trans, we would expect GFP PLK4 KD 6A to show decreased 
phosphorylation at the Thr297 when compared with GFP PLK4 KD control. Indeed, when PLK4 KD 6A is 
coexpressed with Myc PLK4 ND there is a marked decrease in phosphorylation at Thr297, indicative that 
phosphorylation of the phosphocluster occurs in trans in vivo (Figure 4 H,I).  
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Together these results show that trans-autophosphorylation of a phosphocluster regulates Thr297 
phosphorylation, suggesting both the need for a PLK4 concentration threshold, plus the presence of 
sequential events in timing PLK4 phosphorylation and subsequent degradation. 
 
PLK4 degradation in the organism 
Total centriole number can vary between tissues [35] .While cycling cells keep their number of 
centrioles constant between 2 and 4, multiciliated cells assemble 200 to 300 centrioles/basal bodies [35]. 
In the male germline centriole duplication can be uncoupled from the cell cycle. In the female germline, 
centrioles disappear during oogenesis, after which centriole number is reconstituted during fertilization 
with the entry of the sperm centriole ([35], Figure 5A). PLK4 plays a universal role in centriole number 
control [2–5, 36, 37]. Its activity is essential for centriole formation in somatic cells [4, 5] and in the 
germline in Drosophila [2–4, 37], and the formation of multiple centrioles/basal bodies in multiciliated cells 
correlates with very high levels of PLK4 [38]. If SCF/Slimb-mediated degradation of PLK4 is a pathway 
that is always present to control PLK4 levels, and hence centriole number, we would expect it to operate 
in different tissues. Neuroblasts of Slimb mutants in Drosophila show extra centrosomes, suggesting that 
the SCF/Slimb complex is important for PLK4 degradation in vivo in somatic cells [39]. A similar 
phenotype was found in fibroblasts from mice that are mutant for βTrCP. However, direct control of PLK4 
degradation and consequent centriole number by the SCF/Slimb complex has only been shown in somatic 
cells [6–11, 13]. To understand if this mechanism is a general pathway for centriole number control, we 
investigated whether the PLK4 degron is required for regulation of PLK4 levels in both the male and 
female germlines in Drosophila. We created transgenic lines expressing either PLK4 WT or PLK4 ND. The 
constructs were integrated by recombination within the same defined genomic loci to ensure the same 
mRNA expression levels between different lines, thus allowing for direct comparison between PLK4 WT 
and ND protein levels [40].  
The analysis of total PLK4 levels in the female germline revealed a two-fold increase in PLK4 ND 
GFP as compared to the PLK4 WT GFP control (Figure 5 A, B and S5 A). We and others have observed 
that centrioles still disappear during oogenesis, even upon overexpression of high protein levels of PLK4 
in the female germline [2, 3]. However, in virgin females overexpressing high levels of PLK4, upon exit of 
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meiosis, centrioles are formed de novo [3, 37]. We looked into the centriole phenotype of eggs laid by 
virgin females expressing PLK4 WT GFP or PLK4 ND GFP from the same loci and promoter, at a time 
where centriole de novo formation upon PLK4 overexpression was previously described to begin [2]. We 
observed a two fold increase in the number of centrioles formed de novo with expression of PLK4 ND 
GFP when compared with PLK4 WT GFP (Figure 5 C). 
Expression of PLK4 ND in the male germline resulted in a very strong effect on PLK4 levels 
(Figure 5 D, E), using a promoter that becomes active before the meiotic divisions (Bam-Gal4). Using the 
same exposure for both PLK4 WT GFP and PLK4 ND GFP we could observe a much wider band of 
expression of the mutant, showing that ND PLK4 GFP is stabilized after induction of its expression as 
compared to PLK4 WT GFP. PLK4 stabilization was associated with centriole amplification (Figure 5 F, 
G), and male sterility (Figure 5H). Together, these data shows that the PLK4 degron is functional in vivo in 
different tissues and suggests the SCF/Slimb complex is part of a molecular module that generally 
controls centriole number. 
 
Discussion  
PLK4 levels are regulated by the SCF-Slimb/βTrCP E3-ubiquitin ligase complex; as a 
consequence, in the absence of this control several centrioles are generated around each mother [6–13, 
20]. Slimb/βTrCP-containing regulatory circuits normally operate using built-in time delays that couple 
protein degradation to different biological processes [14, 15, 41]. Simultaneous mutation to alanine of the 
two phosphorylatable residues within the PLK4 Slimb/βTrCP phosphodegron was shown to impact on 
PLK4 degradation [7, 9–11, 13, 20]. Moreover, PLK4 degradation via Slimb/βTrCP was reported to be 
mediated by its own activity [6, 10, 20]. Here we show how PLK4 controls its protein levels (Summarised 
in Figure S6). Drosophila PLK4 autophosphorylates both Ser293 and Thr297 residues within the 
phosphodegron recognised by SCF-Slimb/βTrCP (Figure 1 and S1). Here we show that each residue 
within the degron is regulated differently in a PLK4 dependent manner. While phosphorylation of both 
Ser293 and Thr297 occurs in trans only the former depends on PLK4 dimerization (Figure S3). Moreover, 
while Ser293 is critical for PLK4 degradation, phosphorylation of Thr297 maximizes the efficiency of 
degradation (Figure 2). Finally, PLK4 trans-autophosphorylates a phosphocluster that regulates Thr297 
 14 
phosphorylation and binding to Slimb. In summary, two broad mechanisms are likely to ensure a window 
of PLK4 activity before it self-destructs: i) multiple transphosphorylating events are likely to ensure that a 
minimal amount of PLK4 accumulates before it targets itself for degradation; ii) phosphocluster 
phosphorylation ensures an order of events. Finally, we show that PLK4 and the SCF/Slimb complex 
control centriole number in different tissues, being essential both in cultured somatic cells and in the 
germline in the fly (Figure 5 and S5). 
PLK4 self destructs 
A destruction motif, DS/TG(X)2+nS/T, where the Ser/Thr residues are phosphorylated by specific 
kinases [14, 15, 41] is thought to determine the timed degradation of SCF-Slimb/βTrCP substrates [14, 15, 
41]. Here we show for the first time that PLK4 phosphorylates both Ser293 and Thr297 residues within the 
degron (Figure 1 and 4 A). We could not detect phosphorylation in the PLK4 KD mutant in vivo (Figure 1 
D), showing that no other kinase can account for phosphorylation of those sites in a PLK4-independent 
manner in vivo. Detection of phosphorylated PLK4 in bacteria in both residues (Figure 1 B, S1 E, 4 A and 
S 4A) shows that PLK4 can target these sites directly. Moreover, reactivation experiments using purified 
PLK4 show that autophosphorylation in the degron can occur within a very short time in vitro, supporting 
the specificity of this mechanism (Figure 1C). It is still formally possible that another kinase might target 
the degron in a PLK4 dependent manner. However, a kinome RNAi screen assaying PLK4 levels failed to 
produce a candidate [6], supporting our evidence that PLK4 regulates its own degradation in a direct 
manner. 
Deciphering the PLK4 degron, a phosphocluster and the accuracy of PLK4 degradation 
SCF-Slimb/βTrCP-mediated degradation normally requires phosphorylation of both phospho-
residues within a typical degron [14, 15, 41], but each residue may have different roles in the regulation of 
degradation [42, 43]. We show for the first time that Ser293 and Thr297 within the PLK4 degron have 
different contributions for PLK4 degradation, the Ser293A mutation rendered PLK4 as stable as the ND or 
KD form, whereas PLK4 T297A showed slower degradation (Figure 2 and S1 A, B). It is thus likely that 
Ser293 is the docking residue to bind to Slimb as in other substrates of this complex [43], being critical but 
not sufficient to ensure accurate PLK4 destruction. Thr297 phosphorylation might increase PLK4-Slimb 
affinity and thus accelerate targeting and maximise timely destruction of PLK4. In accordance with this we 
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found that mutagenesis of Thr297A alone impairs binding to Slimb (Figure S4 B). Individual 
phosphorylation of both residues is thus critical as expression of GFP PLK4 Thr297A or GFP PLK4 
Ser293A mutants led to significant centrosome amplification (Figure 2 B, C).  
We investigated a phosphocluster that regulates the phosphorylation of Thr297 and maximizes the 
efficiency of PLK4 degradation. Most of the conserved Ser around the PLK4 degron fit into the broad 
PLK4 consensus (reviewed in [21]) and are phosphorylated in vitro by PLK4 (Figure 4 A and S 4A). 
Moreover mutation of those residues (6A mutant), leads to impaired phosphorylation at the Thr297 
residue within the degron in vivo. This mutant shows less binding to Slimb, slower degradation of PLK4 
and centriole amplification (Figure 4 and S 4). It is possible that those residues additionally regulate 
binding to Slimb/βTrCP in a Thr297 independent manner, perhaps by increasing the negative charges that 
interact with the positive charged amino acids in βTrCP/Slimb, which play crucial role in binding to the 
destruction motif of the substrate (e.g., β-catenin [27]). 
Mechanisms coupling PLK4 activity and degradation  
While degradation of other substrates of Slimb/βTrCP is determined by extrinsic factors, such as the 
activity of degron kinases, we have uncovered two aspects of PLK4 degron autophosphorylation that may 
provide a window of time for PLK4 to promote centriole biogenesis before it autodestructs. First, since 
phosphorylation occurs in trans in all phosphorylation events tested, a minimal concentration of PLK4 
needs to be present before a PLK4 molecule encounters another and phosphorylates it. Thus, the 
requirement for Thr297 regulatory phosphorylations, and the fact that they occur in trans, contributes to 
further delay full degron phosphorylation, ensuing timely PLK4 degradation and centriole number control.  
How is PLK4 autoregulation linked to timing centriole biogenesis in the cell cycle? Both PLK4 
mRNA and protein levels increase from interphase to mitosis ([20, 44] and our own unpublished results). 
Higher PLK4 levels in mitosis suggest that PLK4 attains higher activity at this stage and therefore is likely 
to be more phosphorylated at the degron. However, it has been shown that PP2A/Twins phosphatase 
counteracts Slimb mediated degradation of PLK4 in mitosis [6]. One possibility is that an additional layer 
of regulation is conferred by the concerted action of this and/or other phosphatases at both the degron 
phospho-residues and phosphocluster that surrounds them. The combination of the factors discussed 
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here is likely to lead to the described maximum PLK4 levels found in mitosis, linking to the cell cycle and 
perhaps other aspects of cellular physiology, before PLK4 promotes its own degradation. 
Implications of PLK4 degradation in vivo 
Previous work showed that PLK4 and Zyg1 regulation by the SCF/Slimb complex is essential in 
Human and Drosophila somatic tissue culture cells and C. elegans embryos [6–13]. Neuroblasts from 
Drosophila Slimb mutants [39] and fibroblasts from βTrCP mutant mice [45] also show centrosome 
amplification, suggesting that regulation of PLK4 by this ubiquitin ligase is also important in somatic cells 
in vivo in Drosophila. However, those phenotypes in flies and mice could be due to misregulation of other 
Slimb/βTrCP substrates. We now show that the SCF/Slimb complex regulates PLK4 levels in vivo, being 
required for centriole number control in both the female and male germline and impacting on their fertility. 
The SCF/Slimb and PLK4 generally control centriole number in animals and are deregulated in many 
cancers. Centriole number is altered in the majority of cancers and its manipulation is widely discussed for 
diagnosis and therapeutics [14–17]. The knowledge that βTrCP controls centriole number in different 
tissues may offer new opportunities to interfere with centriole number in disease.  
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Figures and Legends 
 
Figure 1. PLK4 targets itself for degradation by autophosphorylation of both Ser293 and Thr297 
residues within the degron. (A) Consensus degron in PLK4 sequence for Slimb binding. Position of 
the first aminoacid residue is shown. Degron is highlighted in gray and mutated Ser293 and/or Thr297 to 
alanine are shown in red. PLK4 WT, wild type; PLK4 S293A, S293 was mutated to alanine; PLK4 T297A, 
T297 was mutated to alanine; PLK4 ND, non-degradable, both residues were mutated to alanine. (B) 
PLK4 autophosphorylates the degron directly in bacteria. pGEX-2RBS-GST PLK4 WT, WT + λppase 
and KD were expressed in bacteria at 25ºC. The soluble fractions were probed for p-PLK4-Ser293 (M) or 
p-Thr297 and GST. Note that with PLK4 KD or WT co-expressed with λppase there is no 
autophosphorylation of either Ser293 or Thr297 residues. PLK4 is highly autophosphorylated in bacteria, 
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leading to the appearance of a smear, which disappears upon expression of the phosphatase. We always 
observed the appearance of a lower mobility form, which might be the product of degradation. (C) PLK4 
autophosphorylates the Ser293 and Thr297 in vitro. Autophosphorylation of purified dephosphorylated 
His MBP PLK4 was followed for 60 minutes after reactivation of the kinase, following addition of ATP. 
Samples were taken at the indicated time points and tested by western blot for phosphorylation at the 
Ser293 and Thr297 residues. Note that phosphorylation on the two residues is absent from the sample 
where ATP was not added, while a very faint signal can be seen as soon as ATP is added (0 mins) and 
clearly after 10 min, reinforcing the specificity of the phosphorylation. A likely product of degradation is 
always seen below the PLK4 band (D) PLK4 autophosphorylates the degron in vivo. DMEL cells 
transiently transfected with pMT-GFP PLK4 WT, S293A, T297A, ND, KD, KDND (both KD and ND 
mutations) constructs after endogenous PLK4 depletion were induced with 500 µM CuSO4. Cell extracts 
were then prepared and analyzed by western blotting for p-PLK4 Ser293 (M) or p-PLK4 Thr297 and GFP 
(to detect total PLK4). Note that contrary to PLK4 WT, the PLK4 KD mutant is not phosphorylated at both 
degron sites. The ND mutant is highly stabilized and autophosphorylated; combination of the ND, KD 
(NDKD) mutations abolishes electrophoretic mobility (See also Figure S1 and S2). 
 22 
 
Figure 2. Phosphorylation of the Ser293 residue within PLK4 degron is critical, while 
phosphorylation of Thr297 maximises the efficiency of PLK4 degradation and centriole number 
control. (A, B) Mutation of Ser293 to alanine blocks PLK4 degradation. (A) pMT-ProtA PLK4 WT, 
S293A, T297A or ND transfected DMEL cells were induced with CuSO4 so that similar levels of protein 
where present at the beginning of the pulse-chase. Cells were washed 18 hours later, incubated in 
medium supplemented with cycloheximide, and harvested at the indicated time points. Cell extracts were 
then prepared and analyzed by western blotting for ProtA and actin loading control. (B) Quantification of 
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ProtA PLK4 relative intensity values shown in panel (A). These values were normalized to the actin 
loading control. Three independent experiments were used to generate the average for each time point. 
Error bars represent ± SEM. Note that while both ProtA PLK4 S293A and PLK4 ND remain stable, ProtA 
PLK4 WT and T297A levels decrease with time. (C, D) Phosphorylation of both Ser293 and Thr297 
residues is required to control centriole number. (C) DMEL cells were transiently transfected with 
pMT-GFP PLK4 WT, S293A, T297A or ND constructs in an endogenous PLK4 RNAi background (PLK4). 
Due to the leaky nature of the metallothionein promoter (pMT), the experiments were conducted in a non-
induced context. To score centrioles, cells were fixed and stained against D-PLP and DNA 
(counterstained with DAPI). Data are the average of 3 independent experiments ± SEM (n=100 cells in 
each experiment). Expression of PLK4 S293A, T297 and ND constructs led to a statistically significant 
increase in centrosome amplification (more than 4 centrioles) when compared to PLK4 WT (*** p<0,001, 
** p<0,01, using Pearson’s χ2 test). RNAi for PLK4 results in an increase in cells with 0 and 1 centrioles 
that is not fully rescued with expression of the WT construct, and is partially rescued with the other more 
stable constructs (for phenotype in the absence of depletion of endogenous PLK4 please see 
Supplemental Figure 2). (D) Representative images of cells analyzed in panel (C) GFP PLK4 proteins are 
represented in green, D-PLP in red, and DNA in blue. Individual cells are outlined by dashed lines that 
represent the cell outline as judged by the D-PLP background signal. Scale bar=10µm (See also Figure 
S2).  
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Figure 3. PLK4 trans-autophosphorylates the Slimb degron. (A) Schematic representation of PLK4 
trans auto-phosphorylation and expected regulation of protein levels. PLK4 has a triple polo box 
architecture that facilitates oligomerization and targeting ([8, 30], here generally called PBD). Trans-
phosphorylation might be dependent or not on dimerization through the polo-boxes, in particular PB1-PB2 
[8, 11]. (B, C) PLK4 trans-autophosphorylates the Slimb degron. (B) Trans-autophosphorylation 
destabilizes PLK4 KD. left, Cell extracts were prepared and analyzed by western blotting for GFP (to 
detect GFP PLK4 KD) and Myc (to detect Myc PLK4 WT). Note that in the presence of Myc PLK4 WT, 
GFP PLK4 KD becomes phosphorylated (lower mobility bands). Right, Cell extracts were analyzed by 
western blotting for Myc and PLK4 antibodies (for comparison of PLK4 expression under the act5 (PLK4 
WT) and pMT promoter (PLK4 KD – expressed 52 fold more)). (C) PLK4 trans-auto phosphorylates 
both the Ser293 and Thr297 residues. Combinations (as indicated) of act5-Myc PLK4 WT, pMT-GFP 
PLK4 KD and pMT-GFP constructs were transfected in DMEL cells after endogenous depletion of PLK4 
(PLK4). The pMT constructs were induced with 500 µM CuSO4, to ensure higher protein expression as 
compared to the act5 promoter. Note that co-expression of Myc PLK4 WT leads to phosphorylation of 
 25 
both Ser293 and Thr297 in a PLK4 KD mutant. Note that since Myc PLK4 WT is expressed at much lower 
levels (panel B, right) it is impossible to detect its phosphorylation in the left lane (See also Figure S2 and 
S3). 
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Figure 4. A phosphocluster outside the PLK4 degron controls phosphorylation within the degron, 
PLK4 degradation and centriole numbers. (A) Alignment of D. melanogaster and M. musculus PLK4 
24-amino acid domain [10] shows that 6 phospho-residues outside the degron are conserved. From these 
6 residues, we identified 5, plus Ser293 and Thr297, as being autophosphorylated in vitro by D. 
melanogaster PLK4 (residues highlighted with a black circle (see Figure S4 A for more details on 
experiment and peptides identified by mass spectrometry)). The sequence of the Drosophila PLK4 6 
alanine mutant is also represented. The positions of the first and last amino acid residues are shown. 
Color code: green highlight – conserved residues; red highlight – non-conserved residues. (B, C) 
Mutagenesis to alanine of the six conserved phospho-residues impairs PLK4 degradation. (B) 
pMT-ProtA PLK4 WT, 6A, or ND transfected DMEL cells were induced with CuSO4. Cells were washed 18 
hours later, incubated in medium supplemented with cycloheximide, and harvested at the indicated time 
points. Cell extracts were then prepared and analyzed by western blotting for ProtA and actin loading 
control (the same experimental setup as indicated in Figure 2A). (C) Quantification of ProtA PLK4 relative 
intensity values shown in panel (B). These values were normalized to the actin loading control. Three 
independent experiments were used to generate the average for each time point. Error bars represent ± 
SEM. (D, E) Phosphocluster phosphorylation is required for centriole number control. Cells were 
transiently transfected with pMT-GFP PLK4 WT, T297A or 6A constructs in an endogenous PLK4 RNAi 
background (PLK4). Due to the leaky nature of the metallothionein promoter (pMT), the experiments were 
conducted in a non-induced context. To score centrioles, cells were fixed and stained against D-PLP and 
DNA (counterstained with DAPI). Data are the average of 3 experiments ± SEM (n=100 cells in each 
experiment). Expression of PLK4 T297A and 6A constructs led to a statistically significant increase in 
centrosome amplification (more than 4 centrioles) when compared to PLK4 WT (*** p<0,001, ** p<0,01, 
using Pearson’s χ2 test). RNAi for PLK4 results in an increase in cells with 0 and 1 centrioles that is not 
fully rescued with expression of the WT construct, and is partially rescued with the other more stable 
constructs. (E) Representative images of cells analyzed in panel (D) GFP PLK4 proteins are represented 
in green, D-PLP in red, and DNA in blue. Individual cells are outlined by dashed lines that represent the 
cell outline as judged by the D-PLP background signal. Note that the 6A mutant localizes to centrioles. 
Scale bar=10µm (F, G) Phosphocluster autophosphorylation regulates Thr297 phosphorylation. 
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DMEL cells transiently transfected with pMT-GFP PLK4 WT, S293A, T297A, and 6A constructs after 
endogenous PLK4 (PLK4) depletion were induced with 500 µM CuSO4. Cell extracts were then prepared 
and analyzed by western blotting for p-PLK4 Ser293 (F) or p-PLK4 Thr297 (G) and GFP (to detect total 
PLK4). The relative intensities of p-PLK4 Ser293 (F) or Thr297 (G) residues for each sample were 
obtained by normalization with the respective total PLK4 levels. Quantifications were performed using the 
Odyssey infrared image system (LI-COR). Note that the 6A mutant has impaired phosphorylation at 
Thr297 but not at Ser293 residue. Data are the average of 3 experiments ± SEM. (p=0,0106, t-Test). H) 
Phosphorylation of the phosphocluster occurs in trans in vivo. Combinations (as indicated) of pMT-
GFP PLK4 WT (as a positive control for phosphorylation; low amounts are expressed), pMT-GFP PLK4 
KD, pMT-GFP PLK4 KD 6A, act5-Myc PLK4 ND and GFP and Myc empty constructs were transfected in 
DMEL cells after endogenous depletion of PLK4 (PLK4). The pMT constructs were induced with 500 µM 
CuSO4. Note that individual antibody blots were used to annotate which protein is which in the figure. I) 
Quantification of relative phosphorylation at Thr297 in panel H. The relative intensity of Thr297 for each 
sample was obtained by normalization with the respective total PLK4 levels. Quantifications were 
performed using the Odyssey infrared image system (LI-COR). Note that co-expression of Myc PLK4 ND 
with GFP PLK4 KD 6A leads to a marked reduction in Thr297 phosphorylation when compared with GFP 
PLK4 KD (See also Figure S2 and S4). 
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Figure 5. Phosphorylation at the Slimb degron is critical to control PLK4 stability and centriole 
number in the Drosophila germline. (A) Drosophila early embryogenesis. Centrioles are lost during 
oogenesis. Embryogenesis starts at fertilization when the sperm brings the first centriole of the egg and 
the two pronuclei meet. After the first mitotic division, syncytial divisions begin (Adapted from [46]) (B) 
PLK4 ND GFP protein is stabilized in Drosophila female germline when compared with PLK4 WT 
GFP protein expressed from the same promoter and genomic loci. pUASp-PLK4 WT GFP and 
pUASp-PLK4 ND GFP inserted by recombination in the same genomic loci were expressed under the 
control of the ovariole specific driver V32Gal4. Ovary extracts from 3-day-old females were prepared and 
analysed by western blot with Plk4 antibody (α -Tubulin was used as a loading control). See Figure S3 3 
for results using another insertion line. (C) Expression of pUASp-PLK4 ND GFP leads to higher levels 
of centriole de novo formation as compared to pUASp-PLK4 WT GFP. Note that at thirty minutes after 
egg laying, eggs overexpressing pUASp-PLK4 ND GFP show more centrioles as compared with the WT 
kinase. A magnified view of an area where centrioles are seen is shown. γ-Tubulin in red. PLK4 GFP in 
green. Scale bars are (top) 25 µm and (lower) 50 µm. Inset is 5X magnification. (D) Drosophila 
spermatogenesis. Cysts of 16 primary spermatocytes are formed upon the four mitotic divisions of the 
gonial cell. Each of these cells has four centrioles and undertakes a prolonged G2-phase, where both 
cells and centrioles grow. In meiosis I each centrosome is built up of two centrioles in a V-shape, whereas 
in meiosis II each centrosome contains only one centriole. Meiotic divisions produce a cyst of 64 
interconnected spermatids, each with one centriole (Adapted from [47]). (E) PLK4 ND GFP protein is 
highly stabilized in Drosophila male germline when compared with PLK4 WT GFP protein 
expressed from the same promoter and genomic loci. pUASp-PLK4 WT GFP and pUASp-PLK4 ND 
GFP integrated at recombination site 28E7, were expressed under the male germline specific driver 
BamGal4. Immunostaining of whole mount testes shows that PLK4 ND GFP is stabilized in the male 
germline, being visible in many more cells. See Figure S3 3 for results using another insertion line. (F) 
Expression of PLK4 ND in the male germline leads to centriole amplification. Representative images 
of G2 cysts expressing pUASp-PLK4 WT GFP and pUASp-PLK4 ND GFP from the same promoter and 
genomic loci. Centrioles were immunostained with an antibody against the centrosome and centrioles, 
Drosophila pericentrin like protein (D-PLP) and γ-tubulin and DAPI (nucleus). Note the higher centriole 
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amplification observed upon expression of pUASp- PLK4 ND GFP as compared with pUASp- PLK4 WT 
GFP. (G) Quantification of centriole number in pUASp-PLK4 WT and pUASp-PLK4 ND G2 cysts. 
The average number of centrioles (labelled for D-PLP and γ-tubulin) per each cell in G2 cysts is 
represented. Data are the average of ≥8 cysts (≥128 G2 cells) from each genotype ± S.E.M. Expression of 
PLK4 ND, led to a statistically significant increase in centrosome amplification when compared to PLK4 
WT (***,p<0,001, using Unpaired T test). (H) Males expressing PLK4 ND GFP are sterile. The average 
number of progeny produced by male of depicted genotypes is represented. Note that while males 
expressing pUASp-PLK4 ND GFP are fully sterile, expression of pUASp-PLK4 WT GFP from same 
promoter only leads to partial sterility. W118- Wild type strain with no insertion (See also Figure S5). 
 
 
 
